[Mechanism of the ventricular fibrillation following intravenous adrenaline administration under halothane anesthesia].
D000628:Aminophylline / Q000494:pharmacology; D000769:Anesthesia, Inhalation; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D003992:Dibucaine / Q000494:pharmacology; D004285:Dogs; D004562:Electrocardiography; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000008:administration & dosage* / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D006221:Halothane; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D012118:Resorcinols / Q000494:pharmacology; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D004983:Ethanolamines; D010627:Phenethylamines; D012118:Resorcinols; D000804:Angiotensin II; D010656:Phenylephrine; D000628:Aminophylline; D001285:Atropine; D004809:Ephedrine; D008729:Methoxamine; D007545:Isoproterenol; D003992:Dibucaine; D002746:Chlorpromazine; D006221:Halothane; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine